What Color Tube Is Used for a Comprehensive Metabolic Panel?

A comprehensive metabolic panel (CMP) is drawn into a gold-top tube, formally known as a serum separator tube, or SST. This is the standard across most hospital and outpatient laboratories in the United States. Some labs accept a light-green-top tube containing lithium heparin as an alternative, but the gold-top SST remains the default. The reason comes down to what each tube does to the blood after collection and how that affects the 14 analytes the CMP measures.

What the Gold-Top Tube Actually Does

The gold-top SST contains two key components: a clot activator coating the inner walls and a gel barrier sitting at the bottom. When blood enters the tube, the clot activator encourages the blood to form a solid clot within about 30 minutes. After clotting, the tube is spun in a centrifuge. During centrifugation, the gel, which has a density between blood cells and liquid serum, migrates upward and forms a physical barrier separating the serum on top from the clot below. This barrier prevents the red blood cells, white blood cells, and platelets from continuing to interact with the serum, which stabilizes the sample for testing.

Serum, the liquid portion of blood after clotting, is the preferred specimen type for a CMP at most laboratories. The 14 analytes measured in a CMP include glucose, calcium, sodium, potassium, chloride, carbon dioxide (bicarbonate), blood urea nitrogen, creatinine, albumin, total protein, alkaline phosphatase, ALT, AST, and total bilirubin. All of these can be reliably measured in serum obtained from a properly handled gold-top SST.

When a Light-Green-Top Tube Is Used Instead

Some laboratories, particularly those prioritizing faster turnaround, use a light-green-top tube containing lithium heparin with a gel separator. Lithium heparin is an anticoagulant, meaning it prevents blood from clotting. The sample spun from this tube yields plasma rather than serum. Plasma includes fibrinogen and other clotting factors that serum does not, since those proteins were consumed during the clotting process in an SST.

The practical advantage of lithium heparin tubes is speed. Because you do not need to wait 30 minutes for the blood to clot, the tube can be centrifuged almost immediately after collection. In emergency departments and critical-care settings where minutes matter, this can shave meaningful time off the total result turnaround. However, the switch from serum to plasma is not entirely seamless. A validation study comparing a lithium heparin tube (the BD Vacutainer Barricor) to a standard SST reference found significant biases in several CMP analytes, including AST, glucose, potassium, lactate dehydrogenase, sodium, and total protein.¹ Most of these biases are small and clinically manageable, but they are the reason each laboratory must validate a new tube type against its existing reference before switching.

Research comparing serum and different plasma types at the metabolite level has found measurable differences in amino acids, lactate, pyruvate, and creatinine concentrations depending on tube type.² For routine CMP reporting these differences tend to be minor, but they reinforce why the same tube type should be used consistently when tracking a patient’s results over time. Switching from a gold-top to a green-top between visits can introduce apparent shifts in values that have nothing to do with the patient’s actual health.

Tubes That Should Never Be Used for a CMP

Not every collection tube is compatible with chemistry testing. The most important tube to avoid mixing up with a CMP draw is the lavender-top (purple-top) tube, which contains EDTA. EDTA is an anticoagulant used primarily for complete blood count testing, and it works by chelating, or binding, calcium ions. If blood intended for a CMP is drawn into an EDTA tube or even contaminated with trace EDTA from a previously filled lavender tube, the calcium result will be falsely low. EDTA contamination also tends to produce spuriously elevated potassium, because the potassium salt of EDTA (K2-EDTA or K3-EDTA) adds potassium directly to the sample.

A study examining this problem found that while gross EDTA contamination is easy to spot because of the dramatic drop in calcium and spike in potassium, subtle contamination is relatively common and often goes unrecognized, putting patients at unnecessary risk of harm from incorrect clinical decisions.³ A slightly elevated potassium result could prompt unnecessary repeat draws, urgent cardiac monitoring, or even treatment for a condition the patient does not have. This is one of the reasons the recommended order of draw exists: EDTA tubes are drawn after SST tubes to minimize carryover contamination.

Blue-top tubes (sodium citrate, used for coagulation studies) and gray-top tubes (sodium fluoride/potassium oxalate, used for glucose-specific testing) are also incompatible with a standard CMP. Citrate dilutes the sample, sodium fluoride inhibits glycolysis but interferes with other enzyme assays, and potassium oxalate adds exogenous potassium and chelates calcium.

Why the Order of Draw Matters

When multiple tubes are collected during a single blood draw, the order in which they are filled is standardized to prevent cross-contamination of additives between tubes. The gold-top SST is generally drawn after any blood culture bottles and blue-top coagulation tubes but before the lavender-top EDTA tubes and gray-top tubes. This sequence is designed to keep EDTA and other additives out of the chemistry sample.

A systematic review of the evidence on order of draw found that the risk of cross-contamination depends heavily on the collection system used. With modern closed vacuum systems like standard evacuated tube holders, the possibility of cross-contamination appears to be negligible even if the recommended filling order is not strictly followed. However, when blood is collected using an open system, such as a syringe draw transferred to tubes or a butterfly needle with an initial air-containing tube, following the correct order becomes essential to ensure accurate results.⁴ In practice, most phlebotomists follow the standard order regardless of the collection system, which is a reasonable habit.

Hemolysis and Its Effect on CMP Results

Hemolysis, the rupturing of red blood cells during or after collection, is the single most common cause of rejected or compromised CMP specimens. When red blood cells break open, their contents spill into the serum or plasma. Red blood cells contain high concentrations of potassium, lactate dehydrogenase (LDH), and AST, so hemolysis artificially raises all three values. Potassium is the most clinically dangerous of these because spurious hyperkalemia can trigger urgent and unnecessary interventions.

Research has shown that elevated potassium concentrations due to hemolysis can lead directly to errors in diagnosis and treatment.⁵ The relationship between the degree of hemolysis and the rise in potassium, LDH, and AST has been shown to be linear: the more cells that break, the more these values climb.⁶ Laboratories measure a hemolysis index on every sample and flag or reject results that exceed their threshold. If your CMP results come back with a note about hemolysis or a request to redraw, this is why.

Common causes of hemolysis include using too small a needle for the vein (forcing blood through a narrow gauge), drawing from an IV line, shaking the tube too vigorously, or letting the tube sit too long before processing. Difficult sticks where the phlebotomist probes for the vein can also traumatize cells enough to hemolyze the sample. None of this reflects a problem with the patient, just the collection process.

What Happens After the Tube Is Filled

Proper handling after the blood is in the tube matters as much as choosing the right tube. For a gold-top SST, the standard procedure is to let the tube sit upright at room temperature for 30 minutes to allow complete clotting, then centrifuge it to separate the serum from the clot. That gel barrier formed during centrifugation is not just for transport convenience; it stops ongoing cellular metabolism from altering the results.

When a sample sits too long before being centrifuged, red blood cells continue consuming glucose through glycolysis, causing the glucose value to drop. This decline accelerates at higher temperatures. Meanwhile, after glucose is depleted and ATP production stops, the sodium-potassium pumps in cell membranes lose power, and potassium passively leaks out of cells into the serum, raising the potassium reading. Sodium may drift downward as ions move in the opposite direction. Phosphorus and ALT levels can also climb as cell membranes degrade over time.⁷ The upshot: delayed processing can make glucose look lower and potassium look higher than they actually are, two changes with real clinical consequences.

Most laboratory protocols require CMP samples to be centrifuged within two hours of collection and tested or refrigerated promptly after separation. Samples transported from remote draw stations to a central lab by courier face the greatest risk of delay-related changes. In clinical settings, pneumatic tube systems move samples quickly but can occasionally cause hemolysis through mechanical trauma, which circles back to the same potassium problem.

The Tourniquet Question

Patients sometimes wonder whether the tourniquet applied during a blood draw can throw off their results. It is a reasonable concern because a tourniquet causes blood to pool in the arm, concentrating cells and proteins above the constriction point. In theory, a prolonged tourniquet could elevate protein-bound analytes and potassium.

In practice, research comparing blood drawn at 30 seconds versus 60 seconds of tourniquet time found no statistically significant differences in any of the standard CMP analytes, including glucose, electrolytes, kidney markers, liver enzymes, and proteins.⁸ The changes were all within acceptable analytical precision limits. So while extremely prolonged tourniquet application (multiple minutes, as might happen during a difficult draw) could theoretically affect results, a normal one-minute application is not a concern for your CMP values.

Fasting and Other Patient-Side Factors

Whether you need to fast for a CMP depends on your lab and your doctor’s order, but most providers recommend an overnight fast of 8 to 12 hours. The primary analyte affected by eating is glucose: a meal shortly before the draw will obviously raise blood sugar. Triglycerides are not part of a CMP, but if your provider ordered a lipid panel alongside the CMP (which is common), fasting becomes important for that reason as well.

Calcium, albumin, and total protein are relatively stable regardless of food intake. Electrolytes like sodium and potassium are influenced more by hydration status than by what you ate. Drinking water before a fasting blood draw is fine and generally encouraged, as adequate hydration makes veins easier to find and reduces the chance of a difficult stick that leads to hemolysis.

Some medications affect CMP results. Diuretics are the most common culprit, altering sodium, potassium, and bicarbonate. ACE inhibitors can raise potassium. Statins can elevate liver enzymes. Your provider should know what you are taking and will interpret results accordingly, but if you are ever unsure whether to take a medication before a blood draw, ask the ordering clinician rather than skipping doses on your own.

Pediatric and Special Draws

In pediatric settings, especially for newborns and infants, the volume of blood that can safely be drawn is much smaller than in adults. Standard adult evacuated tubes hold 3 to 10 mL, which can represent a meaningful fraction of a small child’s total blood volume. Pediatric micro-collection tubes (sometimes called microtainers) hold well under a milliliter and can collect blood from a heel stick or finger stick rather than a full venipuncture. These come in gold-top or amber-top versions with the same clot activator and gel separator chemistry as their full-sized counterparts, just scaled down.

Capillary specimens do come with trade-offs. Hemolysis rates are higher with heel and finger sticks because squeezing the puncture site to obtain enough blood can damage red blood cells. Potassium elevations from hemolysis in capillary samples tend to be even higher than those seen in venous hemolyzed samples.⁵ This means labs interpreting pediatric capillary CMP results need to be especially vigilant about hemolysis flags. In practice, many pediatric panels are run as basic metabolic panels (BMPs) rather than full CMPs, simply to reduce the required blood volume.

The Difference Between a CMP and a BMP

A basic metabolic panel measures 8 of the 14 CMP analytes: glucose, calcium, sodium, potassium, chloride, bicarbonate, BUN, and creatinine. It drops the liver function markers (ALT, AST, alkaline phosphatase, total bilirubin) and the protein markers (albumin, total protein). Both panels use the same gold-top SST tube. The choice between a BMP and CMP is a clinical one made by the ordering provider, not a tube or specimen issue.

A BMP is often ordered for routine electrolyte and kidney function monitoring, such as for patients on diuretics or those with stable kidney disease. A CMP adds the liver and protein information, making it the standard for annual wellness exams, hospital admissions, and any situation where the provider wants a broader metabolic snapshot. If you are tracking results over time, know which panel was ordered each time, because comparing potassium from a CMP to potassium from a BMP drawn at the same lab on the same tube is perfectly valid, but the missing analytes can lead to confusion if you are looking at a partial panel expecting a full one.

Reading Your Results

When your CMP results come back, each analyte will be reported with a reference range that is specific to the laboratory that ran the test. Reference ranges vary between labs because different analyzers, reagents, and calibration methods produce slightly different numbers. A potassium of 5.1 mmol/L might be flagged as high at a lab whose upper limit is 5.0 but normal at a lab whose range extends to 5.3. This is not a flaw in the system; it reflects real differences in analytical platforms and the populations used to establish each lab’s reference intervals.

This variability is also why you should try to use the same laboratory for serial testing whenever possible. A small shift in creatinine that looks meaningful when comparing results from two different labs may actually be within the normal analytical variation between those platforms. Consistency in tube type, laboratory, and fasting status gives you the cleanest comparison from one draw to the next.